TABLE 3.
Preferred regimens |
Two NRTIs plus either an NNRTI, a ritonavir-boosted PI, or an INSTI (raltegravir) |
Preferred NRTI backbone |
Tenofovir/emtricitabine (coformulated) |
Preferred NNRTI |
Efavirenz |
Preferred ritonavir-boosted PIs |
Atazanavir |
Darunavir |
Preferred regimen for pregnant women |
Lopinavir/ritonavir with zidovudine and lamivudine |